Borderline Personality Disorder, Generalized Anxiety Disorder, Major Depressive Disorder
Conditions
Brief summary
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.
Interventions
OTHERSurvey
Participants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine drug screens, and urine pregnancy tests may be collected.
Sponsors
Adams Clinical
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed. * Participant is at least 18 years old.
Exclusion criteria
* Participant is pregnant, breast-feeding, or planning to become pregnant. * History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results. * Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening. * Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant. * Any condition that in the investigator's opinion makes a participant unsuitable for the study. * Currently employed by Adams Clinical or a first-degree relative of an employee.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study | Up to 52 weeks |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of participants who enroll in industry-sponsored clinical trials | Up to 52 weeks |
| The prevalence of disqualifying comorbid conditions that prevent screening or enrollment in industry-sponsored clinical trials | Up to 52 weeks |
Countries
United States
Contacts
CONTACTMiriam Evans, PhD
Outcome results
None listed